Hans Joenje

19.5k total citations · 2 hit papers
195 papers, 14.1k citations indexed

About

Hans Joenje is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Hans Joenje has authored 195 papers receiving a total of 14.1k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Molecular Biology, 50 papers in Cancer Research and 46 papers in Genetics. Recurrent topics in Hans Joenje's work include DNA Repair Mechanisms (134 papers), Carcinogens and Genotoxicity Assessment (48 papers) and CRISPR and Genetic Engineering (34 papers). Hans Joenje is often cited by papers focused on DNA Repair Mechanisms (134 papers), Carcinogens and Genotoxicity Assessment (48 papers) and CRISPR and Genetic Engineering (34 papers). Hans Joenje collaborates with scholars based in Netherlands, United States and United Kingdom. Hans Joenje's co-authors include Johan P. de Winter, Anneke B. Oostra, Fré Arwert, Quinten Waisfisz, Martin A. Rooimans, Christopher G. Mathew, Ketan J. Patel, Maureen E. Hoatlin, Gilles Thomas and Hiskias G. Keizer and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Hans Joenje

192 papers receiving 13.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biallelic Inactivation of BRCA2 in Fanconi Anemia

2002 859 citations Niall G. Howlett, Toshiyasu Taniguchi et al. Science profile →
Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity

1990 447 citations Hans Joenje et al. profile →

Peers

Countries citing papers authored by Hans Joenje

Since Specialization

Citations

This map shows the geographic impact of Hans Joenje's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Joenje with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Joenje more than expected).

Fields of papers citing papers by Hans Joenje

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Joenje. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Joenje. The network helps show where Hans Joenje may publish in the future.

Co-authorship network of co-authors of Hans Joenje

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Joenje. A scholar is included among the top collaborators of Hans Joenje based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Joenje. Hans Joenje is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BIRC2–BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia 2022 ·Scientific Reports ·(unknown), Yvonne de Jong, (unknown), (unknown), Klaas de Lint, Daoud Sie, Martin A. Rooimans, Davy Rockx, Elizabeth E. Hoskins, Najim Ameziane, Rob M.F. Wolthuis, Hans Joenje, Susanne I. Wells, Josephine C. Dorsman	7
2	2018 ·Data Archiving and Networked Services (DANS) ·Peter C. van den Akker, Anna M.G. Pasmooij, Hans Joenje, Robert M.W. Hofstra, Gerard J. te Meerman, Marcel F. Jonkman	10
3	Defects in the Fanconi Anemia Pathway and Chromatid Cohesion in Head and Neck Cancer 2015 ·Cancer Research ·Chantal Stoepker, Najim Ameziane, Petra van der Lelij, Irsan Kooi, Anneke B. Oostra, Martin A. Rooimans, Saskia E. van Mil, Arjen Brink, Ralf Dietrich, Jesper A. Balk, Bauke Ylstra, Hans Joenje, Stephan M. Feller, Ruud H. Brakenhoff	25
4	Spontaneous abrogation of the G2 DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients 2010 ·Journal of Clinical Investigation ·Raphaël Ceccaldi, Delphine Briot, Jérôme Larghero, Nadia Vasquez, Catherine Dubois d’Enghien, Delphine Chamousset, (unknown), Quinten Waisfisz, Olivier Hermine, Corinne Pondarré, Thierry Leblanc, Éliane Gluckman, Hans Joenje, Dominique Stoppa‐Lyonnet, Gèrard Socié, Jean Soulier	49
5	Clinical and Molecular Characteristics of Squamous Cell Carcinomas From Fanconi Anemia Patients 2008 ·JNCI Journal of the National Cancer Institute ·(unknown), Peter J.F. Snijders, (unknown), Éliane Gluckman, Jean Soulier, Jordi Surrallés, María Castellà, Jacqueline E. van der Wal, Johan Wennerberg, Joseph A. Califano, Eunike Velleuer, Ralf Dietrich, Wolfram Ebell, Elisabeth Bloemena, Hans Joenje, C. René Leemans, Ruud H. Brakenhoff	80
6	The nuclear accumulation of the Fanconi anemia protein FANCE depends on FANCC 2006 ·DNA repair ·France Léveillé, Miriam Ferrer, Annette L. Medhurst, El Houari Laghmani, Martin A. Rooimans, (unknown), Jûrgen Steltenpool, Tom A. Titus, John H. Postlethwait, Maureen E. Hoatlin, Hans Joenje, Johan P. de Winter	20
7	Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2 2006 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Barbara C. Godthelp, Paul P.W. van Buul, Nicolaas G.J. Jaspers, (unknown), Annemarie van Duijn-Goedhart, Fré Arwert, Hans Joenje, Małgorzata Z. Zdzienicka	38
8	The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J 2005 ·Nature Genetics ·Marieke Levitus, Quinten Waisfisz, Barbara C. Godthelp, Yne de Vries, Shobbir Hussain, Wouter W. Wiegant, (unknown), Jûrgen Steltenpool, Martin A. Rooimans, Gerard Pals, Fré Arwert, Christopher G. Mathew, Małgorzata Z. Zdzienicka, Kevin Hiom, Johan P. de Winter, Hans Joenje	338
9	Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia 2003 ·European Journal of Human Genetics ·Marc Tischkowitz, Najim Ameziane, Quinten Waisfisz, Peter de Winter, R. J. C. Harris, Reinhard Stöger, Shirley Hodgson, Christopher G. Mathew, Hans Joenje	7
10	Spectrum ofFANCA mutations in Italian Fanconi anemia patients: Identification of six novel alleles and phenotypic characterization of the S858R variant 2003 ·Human Mutation ·Michelangelo Savino, Adriana Borriello, Maria D’Apolito, Maria Criscuolo, Maria Del Vecchio, Anna Monica Bianco, (unknown), Rita Calzone, Brúno Nobili, Adriana Zatterale, Leopoldo Zelante, Hans Joenje, Fulvio Della Ragione, Anna Savoia	26
11	Biallelic Inactivation of BRCA2 in Fanconi Anemia breakdown → 2002 ·Science ·Niall G. Howlett, Toshiyasu Taniguchi, Susan B. Olson, Barbara Cox, Quinten Waisfisz, Christine de Die‐Smulders, Nicole S. Persky, Markus Grompe, Hans Joenje, Gerard Pals, Hideyuki Ikeda, Edward A. Fox, Alan D. D’Andrea	859
12	Impaired DNA damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi anemia group D1 2002 ·Oncogene ·Barbara C. Godthelp, (unknown), Hans Joenje, Małgorzata Z. Zdzienicka	78
13	Analysis of baseline and cisplatin-inducible gene expression in Fanconi anemia cells using oligonucleotide-based microarrays 2002 ·PubMed ·Quinten Waisfisz, Akira Miyazato, Johan P. de Winter, Johnson M. Liu, Hans Joenje	8
14	Isolation of a cDNA Representing the Fanconi Anemia Complementation Group E Gene 2000 ·The American Journal of Human Genetics ·Johan P. de Winter, France Léveillé, Carola G.M. van Berkel, Martin A. Rooimans, Laura van der Weel, Jûrgen Steltenpool, Ilja Demuth, Neil V. Morgan, Noa Alon, Lucine Bosnoyan-Collins, Jeff Lightfoot, Peter A. J. Leegwater, Quinten Waisfisz, Kenshi Komatsu, Fré Arwert, Jan C. Pronk, Christopher G. Mathew, Martin Digweed, Manuel Buchwald, Hans Joenje	175
15	The Fanconi Anemia Group E Gene, FANCE, Maps to Chromosome 6p 1999 ·The American Journal of Human Genetics ·Quinten Waisfisz, Çiğdem Altay, Peter A. J. Leegwater, Johan P. de Winter, Kenshi Komatsu, D. Gareth Evans, Rolf‐Dieter Wegner, André Reis, Hans Joenje, Fré Arwert, Christopher G. Mathew, Jan C. Pronk, Kathrin Saar, Neil V. Morgan, Martin Digweed	41
16	Localisation of a Fanconi anaemia gene to chromosome 9p 1998 ·European Journal of Human Genetics ·Kathrin Saar, Detlev Schindler, Rolf‐Dieter Wegner, André Reis, Thomas F. Wienker, Holger Hoehn, Hans Joenje, Karl Sperling, Martin Digweed	17
17	Mutations of the Fanconi Anemia Group A Gene (FAA) in Italian Patients 1997 ·The American Journal of Human Genetics ·Michelangelo Savino, Leonarda Ianzano, Pierluigi Strippoli, Ugo Ramenghi, (unknown), Gian Paolo Bagnara, Hans Joenje, Leopoldo Zelante, Anna Savoia	51
18	Comparative genomic hybridization: A new tool in cancer pathology 1996 ·Human Pathology ·(unknown), Gerrit A. Meijer, Jan P. A. Baak, Hans Joenje, (unknown)	59
19	Hepatoma cells adapted to proliferate under normally lethal hyperthermic stress conditions show rapid decay of thermoresistance and heat shock protein synthesis when returned to 37°C 1995 ·International Journal of Hyperthermia ·J. van Rijn, Jaap van den Berg, J. E. M. Souren, R. van Wijk, Hans Joenje	11
20	Effect of N-acetylcysteine on the antiproliferative action of X-rays or bleomycin in cultured human lung tumor cells 1989 ·Journal of Cancer Research and Clinical Oncology ·(unknown), J. van Rijn, L.E.C.M. Blank, J. Haveman, (unknown), Hans Joenje	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact